GenSight Biologics
GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
9
Funding Rounds
$231.7m
Money raised
Overview
GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
-
Website:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** al*** sa*** | - | - | - |
| Be Gi*** |
|
- | |
| C锟� Mo**** | - | - | |
| Pe*** Go*** | - | - |
Funding series
Funding Series Analysis
The company GenSight Biologics has raised a total of $41.67m in funding over 9 rounds.
Key Insights:
- GenSight Biologics Series A round: $41.67m
- GenSight Biologics Series B round, July 2015: $36m
- GenSight Biologics Series A round, April 2013: $38.42m
- GenSight Biologics Venture round, June 2017: $27.02m
- GenSight Biologics Venture round, February 2019: $9.61m
- GenSight Biologics Venture round, December 2019: $18.01m
- GenSight Biologics Venture round, October 2020: $25m
- GenSight Biologics Venture round, March 2021: $36.02m
GenSight Biologics Series A round
$41.67m
GenSight Biologics Series B round, July 2015
$36m
GenSight Biologics Series A round, April 2013
$38.42m
GenSight Biologics Venture round, June 2017
$27.02m
GenSight Biologics Venture round, February 2019
$9.61m
GenSight Biologics Venture round, December 2019
$18.01m
GenSight Biologics Venture round, October 2020
$25m
GenSight Biologics Venture round, March 2021
$36.02m
Industries
GenSight Biologics is active in the following industries: